Literature DB >> 20690074

Neuro-endocrine and neuropsychological outcome after aneurysmal subarachnoid hemorrhage (aSAH): a prospective cohort study.

A Lammert1, H Bode, H-P Hammes, R Birck, M Fatar, K Zohsel, J Braun, K Schmieder, M Diepers, G A Schubert, M Barth, C Thomé, M Seiz.   

Abstract

OBJECTIVE: Neuropsychological sequelae are common after aneurysmal subarachnoid hemorrhage (aSAH) and may be associated with or caused by supposed hypothalamic-pituitary dysfunction. We evaluated the incidence of neuro-endocrine and neuropsychological deficits after aSAH and their interrelations in a standardized manner.
METHODS: 26 patients (20 females) were prospectively screened for neuro-endocrine and neuropsychological deficits 3 and 6 months after aSAH. We measured GH, IGF-1, prolactin, LH, FSH, estradiol, TSH, fT4, total T3, testosterone, ACTH as well as cortisol before and after ACTH-stimulation. Neuropsychological analysis covered verbal comprehension, short term and working memory, visuospatial construction, figural memory, psychomotor speed, attention, and concentration.
RESULTS: After 3 months central hypogonadism was observed in 2 patients accompanied by central hypothyroidism in 1 male subject. Central hypogonadism resolved spontaneously after 6 months in both. After 3 months, neuropsychological deficits were detected in 57% of the examined patients (44% attention deficits, 38% memory impairment, 12% psychomotor deficits). Neuropsychological deficits were still present in 53% after 6 months.
CONCLUSION: We found a low prevalence of neuro-endocrine and a high prevalence of neuropsychological deficits in patients 3 and 6 months after aSAH. Thus, the absent co-incidence of central hormonal and psychological dysfunction leaves a causal association questionable. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2010        PMID: 20690074     DOI: 10.1055/s-0030-1262815

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

1.  Three years prospective investigation of pituitary functions following subarachnoid haemorrhage.

Authors:  Z Karaca; F Tanriverdi; A T Dagli; A Selcuklu; F F Casanueva; K Unluhizarci; F Kelestimur
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

2.  Aneurysmal subarachnoid hemorrhage (aSAH) results in low prevalence of neuro-endocrine dysfunction and NOT deficiency.

Authors:  Alexander Lammert; Hinrich Bode; Hans-Peter Hammes; Rainer Birck; Marc Fatar; Katrin Zohsel; Kirsten Schmieder; Gerrit Alexander Schubert; Claudius Thomé; Marcel Seiz
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 3.  Endocrine function following acute SAH.

Authors:  Paul Vespa
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 4.  SAH pituitary adrenal dysfunction.

Authors:  P Vespa
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 5.  Clinical prevalence and outcome impact of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis.

Authors:  Chiara Robba; Susanna Bacigaluppi; Nicola Bragazzi; Andrea Lavinio; Mark Gurnell; Federico Bilotta; David K Menon
Journal:  Pituitary       Date:  2016-10       Impact factor: 4.107

6.  Pituitary dysfunction after aneurysmal subarachnoid haemorrhage: course and clinical predictors—the HIPS study.

Authors:  L Khajeh; K Blijdorp; M H Heijenbrok-Kal; E M Sneekes; H J G van den Berg-Emons; A J van der Lely; D W J Dippel; S J C M M Neggers; G M Ribbers; F van Kooten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-11-06       Impact factor: 10.154

Review 7.  Hypopituitarism after subarachnoid haemorrhage, do we know enough?

Authors:  Ladbon Khajeh; Karin Blijdorp; Sebastian Jcmm Neggers; Gerard M Ribbers; Diederik Wj Dippel; Fop van Kooten
Journal:  BMC Neurol       Date:  2014-10-14       Impact factor: 2.474

8.  Diagnostic value of a ghrelin test for the diagnosis of GH deficiency after subarachnoid hemorrhage.

Authors:  K Blijdorp; L Khajeh; G M Ribbers; E M Sneekes; M H Heijenbrok-Kal; H J G van den Berg-Emons; A J van der Lely; F van Kooten; S J C M M Neggers
Journal:  Eur J Endocrinol       Date:  2013-09-14       Impact factor: 6.664

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.